Calamos Advisors’s Zura Bio ZURA Stock Holding History

Calamos Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200,000	Closed	-$54K	–	1004
2024 Q1	$54K	Buy	+200,000	New	+$709K	﹤0.01%	821

Other funds holding ZURA

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Calamos Advisors's ZURA Position: Q2 2024 in Review

Calamos Advisors sold out of Zura Bio (ZURA) in Q2 2024, closing a stake of 200,000 shares — an estimated $54K sold.

Calamos Advisors first reported a position in ZURA in Q1 2024 and held it in 1 quarter. The position peaked at $54K in Q1 2024. 57 funds tracked by Wall St. Rank hold ZURA as of Q2 2024.

Calamos Advisors reported no remaining Zura Bio position as of Q2 2024 after selling out during the quarter.
Calamos Advisors sold 200,000 Zura Bio shares in Q2 2024, an estimated $54K.
Calamos Advisors first reported a position in Zura Bio in Q1 2024 and held it in 1 quarter.
Calamos Advisors's Zura Bio position peaked at $54K in Q1 2024.
57 funds tracked by Wall St. Rank held Zura Bio as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.